Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris.

Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris. Am J Cardiol. 2008 Jul 15; 102(2):160-4.

View in: PubMed

subject areas

Angina Pectoris
Angina, Unstable
Angioplasty, Balloon, Coronary
Anticoagulants
Female
Hemorrhage
Heparin
Hirudins
Humans
Male
Middle Aged
Peptide Fragments
Platelet Glycoprotein GPIIb-IIIa Complex
Postoperative Complications
Recombinant Proteins
Risk Assessment
Risk Factors
Treatment Outcome

authors with profiles

Daniel H. Steinberg